GET THE APP

Pancreatic Disorders & Therapy
Open Access

ISSN: 2165-7092

+44 1478 350008

Pancreatic Disorders & Therapy : Citations & Metrics Report

Articles published in Pancreatic Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Pancreatic Disorders & Therapy has got h-index 11, which means every article in Pancreatic Disorders & Therapy has got 11 average citations.

Following are the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.

	2022	2021	2020	2019	2018
Year wise published articles	30	28	9	1	7
Year wise citations received	43	44	64	43	36

Journal total citations count	437
Journal impact factor	1.58
Journal 5 years impact factor	3.08
Journal cite score	3.74
Journal h-index	11
Journal h-index since 2018	9

Important citations (368)

elabbasy f, gadde r, hanna mm, sleeman d, livingstone a, etal. (2015) minimally invasive spleen-preserving distal pancreatectomy: does splenic vessel preservation have better postoperative outcomes? a systematic review and meta-analysis. hepatobiliary & pancreatic diseases international 14: 346-353. View at Publisher View at Google Scholar
partelli s, cirocchi r, randolph j, parisi a, coratti a, etal. (2016) a systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein. the surgeon 14: 109-118. View at Publisher View at Google Scholar
rck rajendran s, ecc ejike c, gong m, hannah w, c udenigwe c (2017) preclinical evidence on the anticancer properties of food peptides. protein and peptide letters 24: 126-136. View at Publisher View at Google Scholar
wu x, wu g, wu z, yao x, li g (2015) mir-200a suppresses the proliferation and metastasis in pancreatic ductal adenocarcinoma through downregulation of dek gene. translational oncology 9: 25-31. View at Publisher View at Google Scholar
romney e, nagaraj vj (2015) in vitro model systems to investigate drug resistance mechanisms in pancreatic cancer cells. advances in biological chemistry 5: 286. View at Publisher View at Google Scholar
grant tj, hua k, singh a (2016) chapter six-molecular pathogenesis of pancreatic cancer. progress in molecular biology and translational science 144: 241-275. View at Publisher View at Google Scholar
ma j, zeng f, ma c, pang h, fang b, et al. (2016) synergistic reversal effect of epithelial-to-mesenchymal transition by mir-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. american journal of cancer research 6: 1384. View at Publisher View at Google Scholar
li z, guo j, xie k, zheng s (2015) vitamin d receptor signaling and pancreatic cancer cell emt. current pharmaceutical design 21: 1262-1267. View at Publisher View at Google Scholar
sureban sm, qu d, houchen cw (2015) regulation of mirnas by agents targeting the tumor stem cell markers dclk1, msi1, lgr5, and bmi1. current pharmacology reports 1: 217-222. View at Publisher View at Google Scholar
schiavone m, rampazzo e, casari a, battilana g, persano l, et al. (2014) zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer. disease models & mechanisms 7: 883-894. View at Publisher View at Google Scholar
qu d, johnson j, chandrakesan p, weygant n, may r, aiello n, et al. (2017) doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. plos one 10: e0118933. View at Publisher View at Google Scholar
rck rajendran s, ecc ejike c, gong m, hannah w, c udenigwe c (2017) preclinical evidence on the anticancer properties of food peptides. protein and peptide letters 24: 126-136. View at Publisher View at Google Scholar
wu x, wu g, wu z, yao x, li g (2016) mir-200a suppresses the proliferation and metastasis in pancreatic ductal adenocarcinoma through downregulation of dek gene. translational oncology 9: 25-31. View at Publisher View at Google Scholar
romney e, nagaraj vj (2015) in vitro model systems to investigate drug resistance mechanisms in pancreatic cancer cells. advances in biological chemistry 5: 286. View at Publisher View at Google Scholar
grant tj, hua k, singh a (2016) chapter six-molecular pathogenesis of pancreatic cancer. progress in molecular biology and translational science 144: 241-275. View at Publisher View at Google Scholar
ma j, zeng f, ma c, pang h, fang b, et al. (2016) synergistic reversal effect of epithelial-to-mesenchymal transition by mir-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. american journal of cancer research 6: 1384. View at Publisher View at Google Scholar
li z, guo j, xie k, zheng s (2015) vitamin d receptor signaling and pancreatic cancer cell emt. current pharmaceutical design 21: 1262-1267. View at Publisher View at Google Scholar
sureban sm, qu d, houchen cw (2015) regulation of mirnas by agents targeting the tumor stem cell markers dclk1, msi1, lgr5, and bmi1. current pharmacology reports 1: 217-222. View at Publisher View at Google Scholar
schiavone m, rampazzo e, casari a, battilana g, persano l, et al. (2014) zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer. disease models & mechanisms 7: 883-894. View at Publisher View at Google Scholar
qu d, johnson j, chandrakesan p, weygant n, may r, et al. (2015) doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. plos one 10: e0118933. View at Publisher View at Google Scholar
Prev 1 2 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 Next »

Top